Cargando…

Glaucocalyxin B Attenuates Ovarian Cancer Cell Growth and Cisplatin Resistance In Vitro via Activating Oxidative Stress

Ovarian cancer is one of the fatal gynecological cancers around the world. Cisplatin is the first-line chemotherapy drug for the clinical treatment of ovarian cancer. However, many patients with ovarian cancer are still suffering from resistance to cisplatin. Therefore, the new drug combinations or...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Tingting, Xu, Chenxin, Zheng, Peisen, Zhang, Xiaoxian, Qiu, Chenyu, Wu, Fengjiao, Chen, Jundixia, Xiao, Zhongxiang, Zhu, Jiandong, Zhang, Jingjing, Zou, Peng, Ni, Daoyong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8896941/ https://www.ncbi.nlm.nih.gov/pubmed/35251480 http://dx.doi.org/10.1155/2022/6324292

Ejemplares similares

Compensatory combination of mTOR and TrxR inhibitors to cause oxidative stress and regression of tumors
por: Xia, Yiqun, et al.
Publicado: (2021)

Combination therapy with HSP90 inhibitors and piperlongumine promotes ROS-mediated ER stress in colon cancer cells
por: Qiu, Chenyu, et al.
Publicado: (2023)

Protective effects of glaucocalyxin A on the airway of asthmatic mice
por: Chen, Si, et al.
Publicado: (2022)

Preparation, optimization of the inclusion complex of glaucocalyxin A with sulfobutylether-β-cyclodextrin and antitumor study
por: Ren, Lili, et al.
Publicado: (2019)

Isodeoxyelephantopin Inactivates Thioredoxin Reductase 1 and Activates ROS-Mediated JNK Signaling Pathway to Exacerbate Cisplatin Effectiveness in Human Colon Cancer Cells
por: Hong, Lin, et al.
Publicado: (2020)

Glaucocalyxin A suppresses multiple myeloma progression in vitro and in vivo through inhibiting the activation of STAT3 signaling pathway
por: Li, Mei, et al.
Publicado: (2021)

Glaucocalyxin A Ameliorates Myocardial Ischemia-Reperfusion Injury in Mice by Suppression of Microvascular Thrombosis
por: Liu, Xiaohui, et al.
Publicado: (2016)

Glaucocalyxin A Inhibits Platelet Activation and Thrombus Formation Preferentially via GPVI Signaling Pathway
por: Li, Wei, et al.
Publicado: (2013)

A novel strategy for the characterization of glaucocalyxin A metabolites in vivo and in vitro by UHPLC-Q-TOF-MS based on DDA and DIA data acquisitions
por: Sun, Wenjing, et al.
Publicado: (2020)

Glaucocalyxin A Attenuates IL-1β-Induced Inflammatory Response and Cartilage Degradation in Osteoarthritis Chondrocytes via Inhibiting the Activation of NF-κB Signaling Pathway
por: Zhu, Weidong, et al.
Publicado: (2022)

Regulation of Microglia Activity by Glaucocalyxin-A: Attenuation of Lipopolysaccharide-Stimulated Neuroinflammation through NF-κB and p38 MAPK Signaling Pathways
por: Kim, Byung-Wook, et al.
Publicado: (2013)

Glaucocalyxin A Inhibits the Malignant Progression of Epithelial Ovarian Cancer by Affecting the MicroRNA-374b-5p/HMGB3/Wnt-β-Catenin Pathway Axis
por: Chen, Feng, et al.
Publicado: (2022)

Sensitization of gastric cancer cells to alkylating agents by glaucocalyxin B via cell cycle arrest and enhanced cell death
por: Ur Rahman, Muhammad Saif, et al.
Publicado: (2017)

CTRP3 attenuates inflammation, oxidative and cell death in cisplatin induced HK-2 cells
por: Zou, Chenglin, et al.
Publicado: (2023)

Glaucocalyxin A exerts anticancer effect on osteosarcoma by inhibiting GLI1 nuclear translocation via regulating PI3K/Akt pathway
por: Zhu, Jianwei, et al.
Publicado: (2018)

Isoalantolactone Enhances the Antitumor Activity of Doxorubicin by Inducing Reactive Oxygen Species and DNA Damage
por: Wu, Fengjiao, et al.
Publicado: (2022)

Glaucocalyxin B inhibits cartilage inflammatory injury in rheumatoid arthritis by regulating M1 polarization of synovial macrophages through NF-κB pathway
por: Han, Chenyang, et al.
Publicado: (2021)

Correction for: Glaucocalyxin B inhibits cartilage inflammatory injury in rheumatoid arthritis by regulating M1 polarization of synovial macrophages through NF-κB pathway
por: Han, Chenyang, et al.
Publicado: (2022)

Effects of paclitaxel and cisplatin on in vitro ovarian follicle development
por: Kim, Yoon Young, et al.
Publicado: (2019)

Artesunate sensitizes ovarian cancer cells to cisplatin by downregulating RAD51
por: Wang, Bingliang, et al.
Publicado: (2015)

Glaucocalyxin A Ameliorates Hypoxia/Reoxygenation-Induced Injury in Human Renal Proximal Tubular Epithelial Cell Line HK-2 Cells
por: Hosohata, Keiko, et al.
Publicado: (2021)

Glaucocalyxin A alleviates lipopolysaccharide-induced inflammation and apoptosis in pulmonary microvascular endothelial cells and permeability injury by inhibiting STAT3 signaling
por: Cao, Jianwei, et al.
Publicado: (2022)

Glaucocalyxin A Protects H9c2 Cells Against Hypoxia/Reoxygenation-Induced Injury Through the Activation of Akt/Nrf2/HO-1 Pathway
por: Peng, Zhuo, et al.
Publicado: (2020)

Astaxanthine attenuates cisplatin ototoxicity in vitro and protects against cisplatin-induced hearing loss in vivo
por: Nan, Benyu, et al.
Publicado: (2022)

Anlotinib Exerts Inhibitory Effects against Cisplatin-Resistant Ovarian Cancer In Vitro and In Vivo
por: Ji, Yurou, et al.
Publicado: (2022)

Glaucocalyxin A Attenuates Allergic Responses by Inhibiting Mast Cell Degranulation through p38MAPK/NrF2/HO-1 and HMGB1/TLR4/NF-κB Signaling Pathways
por: Piao, Yihua, et al.
Publicado: (2021)

Activation of hedgehog signaling and its association with cisplatin resistance in ovarian epithelial tumors
por: Song, Xueling, et al.
Publicado: (2018)

Multistage Polymerization Design for g-C(3)N(4) Nanosheets with Enhanced Photocatalytic Activity by Modifying the Polymerization Process of Melamine
por: Zhang, Chao, et al.
Publicado: (2019)

Mechanism of ferroptosis in a rat model of premature ovarian insufficiency induced by cisplatin
por: Du, Rong, et al.
Publicado: (2023)

Atezolizumab and Bevacizumab Attenuate Cisplatin Resistant Ovarian Cancer Cells Progression Synergistically via Suppressing Epithelial-Mesenchymal Transition
por: Zhang, Lei, et al.
Publicado: (2019)

Clarithromycin synergizes with cisplatin to inhibit ovarian cancer growth in vitro and in vivo
por: Zhou, Bo, et al.
Publicado: (2019)

Glaucocalyxin A induces G2/M cell cycle arrest and apoptosis through the PI3K/Akt pathway in human bladder cancer cells
por: Lin, Wenfeng, et al.
Publicado: (2018)

Curcuminoid WZ35 synergize with cisplatin by inducing ROS production and inhibiting TrxR1 activity in gastric cancer cells
por: He, Wei, et al.
Publicado: (2019)

Effects of poly (ADP-ribosyl) polymerase (PARP) inhibitor on cisplatin resistance & proliferation of the ovarian cancer C13(*) cells
por: Zhang, Jingjing, et al.
Publicado: (2013)

Synergistic interaction between cisplatin and taxol in human ovarian carcinoma cells in vitro.
por: Jekunen, A. P., et al.
Publicado: (1994)

VDR activation attenuate cisplatin induced AKI by inhibiting ferroptosis
por: Hu, Zhaoxin, et al.
Publicado: (2020)

lncRNAs are novel biomarkers for differentiating between cisplatin-resistant and cisplatin-sensitive ovarian cancer
por: Li, Qing, et al.
Publicado: (2018)

Double-Negative T Cells Attenuate Cisplatin-Induced Acute Kidney Injury via Upregulating IL-10/AT2R Axis
por: Gong, Jing, et al.
Publicado: (2022)

Progesterone-Calcitriol Combination Enhanced Cytotoxicity of Cisplatin in Ovarian and Endometrial Cancer Cells In Vitro
por: Paucarmayta, Ana, et al.
Publicado: (2020)

Analysis of Secreted Proteins from Prepubertal Ovarian Tissues Exposed In Vitro to Cisplatin and LH
por: Marcozzi, Serena, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_c2he5tdohhuc0ktmneg8qlgts2